Circulating Tumor DNA As A MRD Assessment And Recurrence Risk In Patients Undergoing Curative Intent Resection With Or Without Adjuvant Chemotherapy In Colorectal Cancer: A Meta-analysis

Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Chakrabarti, Anup Kasi
doi: https://doi.org/10.1101/2022.11.04.22281967

Article Information

doi 
https://doi.org/10.1101/2022.11.04.22281967
History 
  • November 7, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Anusha Chidharla*,#,1,
  2. Eliot Rapoport*,2,
  3. Kriti Agarwal3,
  4. Samragnyi Madala4,
  5. Brenda Linares5,
  6. Weijing Sun1,
  7. Sakti Chakrabarti6 and
  8. Anup Kasi1
  1. 1University of Kansas Cancer Center, Kansas City, KS
  2. 2Montefiore, Albert Einstein College of Medicine, Bronx
  3. 3Hackensack University Medical Center, Hackensack, NJ
  4. 4University of Iowa Hospitals and Clinics, Iowa city, Iowa
  5. 5Kansas University Medical Center, Kansas City, KS
  6. 6University Hospitals Seidman Cancer Center, Cleveland, OH
  1. ↵# Corresponding author; email: anushaaedma{at}gmail.com

  1. ↵* Contributed equally as first authors.

Back to top
Posted November 07, 2022.
Download PDF
Data/Code
Email
Circulating Tumor DNA As A MRD Assessment And Recurrence Risk In Patients Undergoing Curative Intent Resection With Or Without Adjuvant Chemotherapy In Colorectal Cancer: A Meta-analysis
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Chakrabarti, Anup Kasi
medRxiv 2022.11.04.22281967; doi: https://doi.org/10.1101/2022.11.04.22281967
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area